ArticleAmerican journal of hematology2022

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.

Torsten Dahlén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.